[13C6]-Bromperidol

[13C6]-Bromperidol is a stable isotope-labeled form of the antipsychotic medication Bromperidol, which is used to treat various mental disorders such as schizophrenia, bipolar disorder and Tourette's syndrome. The medication works by blocking certain neurotransmitters in the brain, specifically dopamine and serotonin receptors, which can help to reduce symptoms such as hallucinations, delusions and agitation. [13C6]-Bromperidol is used in research studies and clinical trials as a tracer molecule to better understand the pharmacokinetics and pharmacodynamics of the drug. It is also used in metabolic studies to investigate the metabolism and distribution of the drug in the body. Chemically, [13C6]-Bromperidol is a derivative of the chemical compound haloperidol, which is classified as a butyrophenone antipsychotic drug. The stable isotope labeling of [13C6]-Bromperidol is achieved by substituting six of the carbon atoms in the molecule with the stable isotope carbon-13. This labeling allows researchers to track the drug's distribution and metabolism in the body using mass spectrometry techniques. Overall, [13C6]-Bromperidol is a valuable tool in the study of antipsychotic medications and their effects on the body. Its stable isotope labeling allows for accurate and precise measurements in research studies and clinical trials, ultimately aiding in the development of more effective treatments for mental illnesses.